Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

RA patients report limited activity at 3 on a 0-10 pain scale

Publish date:: March 2, 2020

Key clinical point: Pain levels of 3 or higher on a 0-10 scale were reported by rheumatoid arthritis (RA) patients to interfere with social activities, household chores, work, and sleep.

Major finding: The average level of pain reported by RA patients that did not interfere with activities was 3 on a 0-10 scale, with 10 being the most severe.

Study details: The data come from questionnaires completed by 3,949 adults with rheumatoid arthritis.

Disclosures: The study was supported by Eli Lilly. Four authors are employees of Eli Lilly, and one author reported serving as an unpaid board member for Eli Lilly. Another author reported receiving a grant from Pfizer.

Citation:

Lee YC et al. Arthritis Care Res. 2020 Feb 14. doi: 10.1002/acr.24170.

This Week's Must Reads

Osteoporosis prevalence in PsA similar to general population,

Swedish registry study finds atopic dermatitis significantly associated with autoimmune diseases,

Weight loss may be paramount lifestyle change in preventing gout,

Gut microbiome influences response to methotrexate in new-onset RA patients,

Early treatment of RA with DMARDs promotes sustained remission,

Must Reads in Rheumatoid Arthritis

Gut microbiome influences response to methotrexate in new-onset RA patients,

Early treatment of RA with DMARDs promotes sustained remission,

Tocilizumab, methotrexate combo equals tocilizumab alone for preventing progression,

Biomarker-based prognostic score identifies cardiovascular risk in RA,

Early life exposure to famine raises risk of RA in adulthood,